Results 21 to 30 of about 4,240 (105)

RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease. [PDF]

open access: yesPLoS ONE, 2014
Machado-Joseph disease or Spinocerebellar ataxia type 3 is a progressive fatal neurodegenerative disorder caused by the polyglutamine-expanded protein ataxin-3. Recent studies demonstrate that RNA interference is a promising approach for the treatment of
Clévio Nóbrega   +5 more
doaj   +1 more source

Pasien Spinocerebellar Ataxia 3 (SCA3) dengan neuropati perifer di Indonesia : laporan kasus

open access: yesJKS (Jurnal Kedokteran Syiah Kuala), 2021
Rationale: Spinocerebellar ataxia (SCA) 3, also known as Machado-Joseph Disease (MJD), is a neurodegenerative disease which involves cerebellum and its afferent and efferent pathways.
Iin Pusparini
doaj   +1 more source

Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets

open access: yesFrontiers in Pharmacology, 2020
Ubiquitination is known as important post-translational modification in cancer-related pathways. Human deubiquitinases (DUBs), with functions of modulating the ubiquitination process, are a family with about 100 proteins.
Chenming Zeng   +10 more
doaj   +1 more source

Machado-Joseph disease in Brazil: from the first descriptions to the emergence as the most common spinocerebellar ataxia

open access: yesArquivos de Neuro-Psiquiatria, 2012
Machado-Joseph disease is an autosomal dominant inherited disorder of Azorean ancestry firstly described in 1972. Since then, several Brazilian researchers have studied clinical and genetic issues related to the disease.
José Luiz Pedroso   +3 more
doaj   +1 more source

Gabapentin for complex regional pain syndrome in Machado-Joseph disease: a case report

open access: yesJournal of Medical Case Reports, 2011
Introduction Chronic pain is a common problem for patients with Machado-Joseph disease. Most of the chronic pain in Machado-Joseph disease has been reported to be of musculoskeletal origin, but now there seems to be different chronic pain in patients ...
Lee Yi-Chung   +3 more
doaj   +1 more source

Machado-Joseph Disease

open access: yesPediatric Neurology Briefs, 1996
The frequency, and clinical, molecular, and neuropathological features of spinocerebellar ataxia 3 (SCA3) and Machado-Joseph disease (MJD) in 125 autosomal dominant cerebellar ataxia (ADCA) families were analyzed at the Service de Neuropathologie ...
J Gordon Millichap
doaj   +1 more source

Machado-Joseph Disease

open access: yesPediatric Neurology Briefs, 1994
A 22-year-old male of Portuguese Azorean descent, presenting at age 16 years with postural instability and falls and developing severe generalized dystonia by age 20 years, is reported from the Center for Research in Neurodegenerative Diseases ...
J Gordon Millichap
doaj   +1 more source

Disartria e doença de Machado-Joseph: relato de caso Dysarthria in Machado-Joseph disease: case report

open access: yesRevista da Sociedade Brasileira de Fonoaudiologia, 2007
O objetivo deste estudo foi descrever os principais aspectos fonoaudiológicos relacionados à fala na doença de Machado-Joseph, em um indivíduo do sexo masculino, selecionado entre outros pacientes portadores desta doença com limitações significativas de ...
Angela Ruviaro Busanello   +2 more
doaj   +1 more source

Clinical evaluation of oropharyngeal dysphagia in Machado-Joseph disease

open access: yesArquivos de Gastroenterologia, 2010
CONTEXT: In Machado-Joseph disease, poor posture, dystonia and peripheral neuropathy are extremely predisposing to oropharyngeal dysphagia, which is more commonly associated with muscular dystrophy.
Sabrina Mello Alves Corrêa   +4 more
doaj   +1 more source

Machado-Joseph disease versus hereditary spastic paraplegia: case report [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2001
Machado-Joseph disease (MJD) is the most common autosomal dominant spinocerebellar ataxia and presents great phenotypic variability. MJD presenting with spastic paraparesis was recently described in Japanese patients.
Hélio A. Ghizoni Teive   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy